Výsledky vyhledávání - "B J, Haertlein"

Administration of a potent antagonist of protease-activated receptor-1 (PAR-1) attenuates vascular restenosis following balloon angioplasty in rats

Autor: P, Andrade-Gordon, C K, Derian, B E, Maryanoff, H C, Zhang, M F, Addo, Cheung Wm, B P, Damiano, M R, D'Andrea, A L, Darrow, L, de Garavilla, A J, Eckardt, E C, Giardino, B J, Haertlein, D F, McComsey

Publikováno v: The Journal of pharmacology and experimental therapeutics. 298(1)

Human platelets possess two distinct thrombin-activated receptors, PAR-1 (protease-activated receptor-1) and PAR-4, whereas human vascular smooth muscle cells possess only PAR-1. Although such thrombin receptors have been studied extensively in vitro

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::18a00983bda7a1b6bd81fc0953668bf9
https://pubmed.ncbi.nlm.nih.gov/11408522

Zobrazit plný text záznamu

Cardiovascular profile of RWJ 29009, a new potassium channel activator, in anesthetized and conscious dogs

Autor: B P, Damiano, E C, Giardino, B J, Haertlein, G L, Stump, J A, Mitchell, R, Falotico

Publikováno v: Journal of cardiovascular pharmacology. 23(2)

RWJ-29009, (6S)-trans(-)-1-(6,7-dihydro-6-hydroxy-5,5-dimethyl-2-nitro-5 H-thieno[3,2-b]pyran-7-yl)-2-piperidinone, is a structurally novel and extremely potent potassium channel activator that may be useful for treatment of hypertension and ischemic

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::8d29535aa42e0174c9f4269af94f5f63
https://pubmed.ncbi.nlm.nih.gov/7511761

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání